Patents by Inventor Robert Dunn-Dufault

Robert Dunn-Dufault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Automated laboratory system and related systems, methods, and devices
    Patent number: 11136190
    Abstract: An automated laboratory system includes a vertical shelving system including a frame and at least one shelf movably mounted to the frame such that the at least one shelf is movable relative to the frame between a docked position and an undocked position, the at least one shelf being configured to carry at least one instrument. The system also includes a robotic device proximate the vertical shelving system and being configured to access the at least one instrument carried by the at least one shelf.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: October 5, 2021
    Assignee: Thermo CRS Ltd.
    Inventors: Jonathan Wittchen, Gary Darnel, Michael Paul Riff, Stephen Wayne Johnson, Dean S. Mulyk, Mark Michael Garner, Robert Dunn-Dufault, Ian Yates, Hansjoerg Werner Haas
  • AUTOMATED LABORATORY SYSTEM AND RELATED SYSTEMS, METHODS, AND DEVICES
    Publication number: 20190241363
    Abstract: An automated laboratory system includes a vertical shelving system including a frame and at least one shelf movably mounted to the frame such that the at least one shelf is movable relative to the frame between a docked position and an undocked position, the at least one shelf being configured to carry at least one instrument. The system also includes a robotic device proximate the vertical shelving system and being configured to access the at least one instrument carried by the at least one shelf.
    Type: Application
    Filed: February 1, 2019
    Publication date: August 8, 2019
    Inventors: Jonathan Wittchen, Gary Darnel, Michael Paul Riff, Stephen Wayne Johnson, Dean S. Mulyk, Mark Michael Garner, Robert Dunn-Dufault, Ian Yates, Hansjoerg Werner Haas
  • Dopamine D4 receptor ligands
    Patent number: 5976497
    Abstract: Described herein are D4 receptor-selective compounds of the formula: ##STR1## wherein R.sup.1 is selected from H and an acid labile protecting group; and R.sup.2 and R.sup.3 are independently selected from H, radioisotopic halo, loweralkoxy and tri(loweralkyl)tin; and salts, solvates or hydrates thereof.Also described is the use of these compounds as pharmaceuticals to treat indications for which a dopamine D4 receptor antagonist is indicated. Radiolabeled compounds are useful particularly to image localization of D4 receptor in the human brain, and can therefore aid in the diagnosis of schizophrenia and other medical conditions in which the D4 receptor is implicated.
    Type: Grant
    Filed: August 4, 1997
    Date of Patent: November 2, 1999
    Assignee: Resolution Pharmaceuticals, Inc.
    Inventors: Alfred Pollak, Robert Dunn-Dufault, David Roe
  • Hydrazino-type N.sub.2 S.sub.2 radionuclide chelating compounds
    Patent number: 5858327
    Abstract: Radionuclide chelating compounds are provided for conjugation to targetting molecules such as proteins, peptides or antibodies. The resulting labelled targetting molecules may be used in diagnosis and therapy.
    Type: Grant
    Filed: March 8, 1996
    Date of Patent: January 12, 1999
    Assignee: Resolutions Pharmaceuticals, Inc.
    Inventors: Alfred Pollak, Robert Kirby, Robert Dunn-Dufault
  • Radiolabeled D4 receptor ligands
    Patent number: 5725838
    Abstract: Herein described are radiolabeled compounds and their precursors useful to image D4 receptors in vivo, of the formula: ##STR1## wherein R is selected from iodo, tri(loweralkyl)tin and a radioisotopically labeled iodide and R.sup.1 is selected from H and alkoxycarbonyl, with the proviso that R is not iodo when R.sup.1 is H.The radiopharmaceutical compounds are useful particularly to image localization of D4 receptor in the human brain, and can therefore aid in the diagnosis of schizophrenia and other medical conditions in which the D4 receptor is implicated.
    Type: Grant
    Filed: November 12, 1996
    Date of Patent: March 10, 1998
    Assignee: Resolution Pharmaceuticals, Inc.
    Inventors: Alfred Pollak, Robert Dunn-Dufault, John Thornback
  • Hydrazino-type radionuclide chelators having an N.sub.3 S configuration
    Patent number: 5659041
    Abstract: Radionuclide chelating compounds are provided for conjugation to targeting molecules such as proteins, peptides or antibodies. The resulting labeled targeting molecules may be used in diagnosis and therapy.
    Type: Grant
    Filed: September 2, 1994
    Date of Patent: August 19, 1997
    Assignee: Resolution Pharmaceuticals, Inc.
    Inventors: Alfred Pollak, Robert A. Kirby, Robert Dunn-Dufault
  • Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
    Patent number: RE46558
    Abstract: Described herein are compositions and methods for preventing and/or treating diseases involving aberrant angiogenesis employing one or more benzo[c]chromen-6-one derivatives.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: September 26, 2017
    Assignee: PALOMA PHARMACEUTICALS, INC.
    Inventors: David I. Sherris, Manjinder Gill, Fupeng Ma, Sanjivanjit Kaur Bhal, Robert Dunn-Dufault, Miklos Feher, Peter Redden, Jonathan Schmidt